1921
Volume 102, Issue 4
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

There is no abstract available for this article.

[open-access] This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.19-0868
2020-04-01
2020-09-22
Loading full text...

Full text loading...

/deliver/fulltext/14761645/102/4/tpmd190868.html?itemId=/content/journals/10.4269/ajtmh.19-0868&mimeType=html&fmt=ahah

References

  1. Garcia HH et al., 2014. Efficacy of combined antiparasitic therapy with praziquantel and albendzole for neurocysticercosis: a double-blind, randomized controlled trial. Lancet Infect Dis 14: 687695.
    [Google Scholar]
  2. Nash TE, O’Connell EM, Hammoud DA, Wetzler L, Ware JM, Mahanty S, 2020. Natural history of treated subarachnoid neurocysticercosis. Am J Trop Med Hyg 102: 7889.
    [Google Scholar]
  3. Krupa K, Krupa K, Pisculli ML, Athas DM, Farrell CJ, 2016. Racemose neurocysticercosis. Surg Neurol Int 7: 12.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.19-0868
Loading
/content/journals/10.4269/ajtmh.19-0868
Loading

Data & Media loading...

Supplemental figure

  • Received : 24 Nov 2019
  • Accepted : 12 Dec 2019
  • Published online : 01 Apr 2020
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error